secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2026-03-02T23:59:59+00:00
Accession:  0001193125-26-084012
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics issues $2.875M in unsecured notes to institutional investors at 20% OID
--------------------------------------------------------------------------------

- Issued $2.875M aggregate principal notes for $2.3M net cash (20% original issue discount).
- Notes mature 30 days after $10M+ equity raise or by June 30, 2026; no cash interest.
- Private placement to three institutional investors; notes are unsecured general obligations.
- Proceeds for working capital; sold under Section 4(a)(2) and Rule 506 of Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526084012/0001193125-26-084012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526084012/d121919d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-084012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer